文献速递中枢神经肿瘤放疗

胶质母细胞瘤复发距离分析用于临床靶区优化

Recurrence distance analysis for clinical target volume optimization in glioblastoma.
PubMed 文献 · Clin Transl Radiat Oncol · 2026-08-12

本研究纳入201例IDH野生型胶质母细胞瘤患者,分析复发距离(RD80)并评估缩小和个体化临床靶区(CTV)边界的可行性。中位RD80为1.2 mm,80%患者RD80≤10.4 mm;GTV体积、脑室下区受累和颗粒下层受累与RD80显著相关。结论提示缩小CTV边界具有潜力,支持进一步前瞻性评估。

要点

  • 201例IDH野生型胶质母细胞瘤患者中位RD80为1.2 mm。
  • 80%患者RD80≤10.4 mm,提示可考虑缩小CTV边界。
  • GTV体积、脑室下区及颗粒下层受累与RD80独立相关。

核心结论

  • 胶质母细胞瘤患者缩小CTV边界具有潜力,支持进一步前瞻性评估。

研究设计与样本

  • 回顾性分析2012至2022年接受标准放化疗后出现复发的201例IDH野生型胶质母细胞瘤患者。

主要发现

  • 末次放疗至疾病进展的中位时间为6.8个月(IQR:4.1-11.8个月)。
  • 中位RD80为1.2 mm(IQR:0-6.0 mm),80%患者RD80≤10.4 mm。
  • 多因素线性回归中,对数转换的GTV体积(β=-0.70,p=3.9e-7)、脑室下区受累(β=0.53,p=0.019)和颗粒下层受累(β=0.51,p=0.032)与对数转换的RD80显著相关。

临床怎么用

  • 对于IDH野生型胶质母细胞瘤,可参考RD80分布及GTV体积、脑室下区和颗粒下层受累情况个体化评估缩小CTV边界的可行性。

局限性

  • 本研究为回顾性分析,缩小CTV边界的可行性尚需前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To analyze the pattern of failure in patients with glioblastoma through recurrence distance analysis, and to evaluate the feasibility of reduced and personalized clinical target volume (CTV-)margins. METHODS: This study included 201 patients with IDH-wildtype glioblastoma who received standard chemoradiation between 2012 and 2022 and subsequently developed tumor recurrence. From these patients, clinical variables, radiotherapy treatment plans, and imaging data were collected. The recurrence distance was defined as the minimum isotropic expansion from the gross tumor volume (GTV) required to encompass 80% of the recurrence volume (RD80). Multiple linear regression modeling with backward elimination was performed to identify variables that correlate with the RD80. RESULTS: Median time between the last radiotherapy fraction and progressive disease was 6.8 months (IQR: 4.1-11.8 months). The median RD80 was 1.2 mm (IQR: 0-6.0 mm). For 80% of the patients in our cohort, the RD80 was ≤10.4 mm. In the final multiple linear regression model, the log-transformed GTV volume (β = -0.70, p = 3.9e-7), involvement of the subventricular zone (β = 0.53, p = 0.019) and involvement of the subgranular zone (β = 0.51, p = 0.032) were significantly associated with the log-transformed RD80. CONCLUSION: This work highlights the potential of reduced CTV-margins in patients with glioblastoma, supporting further prospective evaluation.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Tang PLY, Smits M, van Werkhoven ED, et al. Recurrence distance analysis for clinical target volume optimization in glioblastoma. Clin Transl Radiat Oncol. 2026. PMID: 42633158. doi:10.1016/j.ctro.2026.101258

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。